History of documented clotting/coagulation disorder
History of cancer (within the last year)
Any diagnosis requiring anti-coagulation
History of hypersensitivity reaction to apixaban
Active clinically significant bleeding
Creatinine > 1.5 mg/dL
Participants currently receiving any type of anticoagulation or blood thinning medications, including heparin, low molecular weight heparins, Plavix, aspirin, NSAIDS
Combined P-glycoprotein and strong cytochrome P450 (CYP) 3A4 inhibitor
Combined P-glycoprotein and moderate CYP 3A4 inhibitor
Combined P-glycoprotein inducer and strong CYP 3A4 inducer
Inducers of p-glycoprotein
Strong inducers of CYP 3A4
